SCHEMBL3136334

SCHEMBL3136334

CC1(C)CC(N)CC(C)(C)N1Cc1ccc(Cl)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMPD2 Q01433 1/20 0.39
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
KDM1A O60341 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SIGMAR1 Q99720 1/20 0.37
CXCR3 P49682 2/20 0.36
RCOR1 Q9UKL0 1/20 0.36
P2RX7 Q99572 1/20 0.36
SLC6A2 P23975 2/20 0.35
SLC6A3 Q01959 2/20 0.35
DRD2 P14416 2/20 0.35
DRD4 P21917 2/20 0.35
HTR2A P28223 1/20 0.35
SLC6A4 P31645 1/20 0.35
HRH1 P35367 1/20 0.35
HTR2B P41595 1/20 0.35
CHRNA4 P43681 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1309638 0.84 GAA (0.41) AMPD2MAOAMAOBKDM1ASIGMAR1
SCHEMBL5065428 0.78 IDO1 (0.41) MAOAMAOBKDM1ASLC6A2SLC6A3
SCHEMBL11807403 0.77 KDM4E (0.46) AMPD2KDM4EALDH1A1SIGMAR1CXCR3
SCHEMBL11784258 0.74 KMT2A (0.40) AMPD2ALDH1A1
SCHEMBL3144024 0.74 AMPD2 (0.40) AMPD2KDM4EALDH1A1SIGMAR1DRD2
SCHEMBL11315448 0.73 ELANE (0.36) AMPD2MAOAMAOBKDM1ASIGMAR1
SCHEMBL11139304 0.73 ELANE (0.36) AMPD2MAOAMAOBKDM1ASIGMAR1
SCHEMBL26090521 0.72 ALDH1A1 (0.46) MAOAMAOBKDM1AKDM4EALDH1A1
SCHEMBL11141300 0.71 KMT2A (0.37) AMPD2SIGMAR1GAA
SCHEMBL3140656 0.70 AMPD2 (0.37) AMPD2KDM4EALDH1A1SIGMAR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100081692-A1 Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma ASTRAZENECA AB (SE) 2010-04-01 US disclosed
EP-1945613-A1 NOVEL 1 -BENZYL-4-PIPERIDINAMINES THAT ARE USEFUL IN THE TREATMENT OF COPD AND ASTHMA AstraZeneca AB (SE) 2008-07-23 EP disclosed
WO-2007053082-A1 NOVEL 1 -BENZYL-4-PIPERIDINAMINES THAT ARE USEFUL IN THE TREATMENT OF COPD AND ASTHMA ASTRAZENECA AB (SE) 2007-05-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081692-A1 Novel 1-Benzyl-4-Piperidinamines that are Useful in the Treatment of COPD and Asthma CCR1, CCR4, CCR10 AMPD2 2117/4885MAOA 1899/4885MAOB 2278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.